Reports for NAPROXEN
Ingredient
NAPROXEN
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2024-01-11 | 2024-03-18 | 215719 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2021-10-14 | 2022-02-17 | 147219 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-12-01 | 2023-04-28 | 176779 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-06-08 | 2023-06-21 | 194094 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-04 | 2023-07-14 | 197052 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-10-05 | 2023-12-14 | 206392 |
| VIMOVO | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-07-28 | 2022-12-21 | 165617 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-NAPROXEN EC | Discontinued | 2017-08-24 | 2017-08-24 | 20189 | ||
| MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55130 |
| NAPROSYN | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-07-10 | 2024-08-01 | 232646 |
| NAPROXEN - 250 | 250MG | TABLET | Discontinued | 2024-06-17 | 2024-06-27 | 230707 |
| NAPROXEN - 500 | 500MG | TABLET | Discontinued | 2024-06-17 | 2024-06-27 | 230716 |
| NAPROXEN-375 | 375MG | TABLET | Discontinued | 2024-06-17 | 2024-06-27 | 230710 |